Source: Virtual Congress 2020 – Advances in asthma treatment
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Kiani (Tehran, Islamic Republic of Iran), F. Razavi (Tehran, Islamic Republic of Iran), M. Farahani (Tehran, Islamic Republic of Iran), N. Bandegani (Tehran, Islamic Republic of Iran), J. Valizadeh (Tehran, Islamic Republic of Iran), H. Emami (Tehran, Islamic Republic of Iran), A. Abedini (Tehran, Islamic Republic of Iran). Effectiveness of Nebulized Budesonide in Iranian Patients with Asthma Attack. 2627

Member's Comments

No comment yet.

Related content which might interest you: Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma. Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma Source: International Congress 2018 – Asthma analysis Year: 2018 Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Effectiveness of Mepolizumab in Reducing Asthma Exacerbations in Japan Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Study of Efficacy of Sublingual Immunotherapy in Cases Asthma & Allergic Rhinitis in India Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies Year: 2017 Evaluation of Asthma control and oral corticosteroids in Severe Asthma Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2018 Prescribing Trends of Oral Corticosteroids Among Young Adults with Active Asthma Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Efficacy and safety of fluticasone propionate/formoterol in paediatric patients with asthma Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Metered-dose inhaler albuterol: Evaluation of efficacy and safety of increasing doses in children with acute wheezing Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014 Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 Exacerbations and Eosinophil Levels in ACCESS Cohort Participants Prescribed Inhaled Triple Therapy Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018 FENO Guided Therapy in Asthma: A Non-inferiority Study Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Efficacy and safety of indacaterol acetate on ICS background therapy in asthma Source: International Congress 2014 – Asthma and COPD management Year: 2014 BREEZE: Open-label, Clinical Study to Evaluate the Safety and Tolerability of a Treprostinil Dry Powder Inhaler in Patients with Pulmonary Arterial Hypertension Currently Using Tyvaso Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 The Effect of Bronchial Thermoplasty on Lung Function in Severe Asthma Patients Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction Year: 2018 Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014